Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| P01HL070831 | U.S. NIH Grant/Contract | View source | |
| 2013-0144 | Other Identifier | UW IRB | |
| H-2007-0044 | Other Identifier | UW IRB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institutes of Health (NIH) | NIH |
| National Heart, Lung, and Blood Institute (NHLBI) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Although asthma is likely to be a heterogeneous disease or syndrome, three factors and/or events repetitively emerge for their ability to significantly influence asthma inception in the first decade of life: immune response aberrations, which appear to be defined best by the concept of cytokine dysregulation; lower respiratory tract infections (in particular RSV); and some form of gene by environment interaction that needs to occur at a critical time period in the development of the immune system or the lung. It remains to be firmly established, however, how any one or all of these factors, either independently or interactively, influence the development of childhood asthma. Thus, our efforts to determine and define the importance of these three factors to asthma pathogenesis are the focus and goal of this current grant application.
No more description necessary.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Evaluate the children longitudinally for the inception and progression of asthma. | Clinical diagnosis of childhood asthma at age 6 years and older. | Birth through age 19 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
High risk birth cohort of children (one or both parents have allergies and/or asthma).
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Daniel J Jackson, MD | University of Wisconsin, Madison | Principal Investigator |
| Robert F Lemanske, Jr., MD | University of Wisconsin, Madison | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Wisconsin | Madison | Wisconsin | 53792 | United States |
Not provided
| Label | URL |
|---|---|
| study web page | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D001249 | Asthma |
| D006967 | Hypersensitivity |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
nasal mucus samples, cord blood, peripheral blood samples, nasal cell brushing samples, cell lines
| D012130 |
| Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D007154 | Immune System Diseases |